Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0633

-1.9%

12:39 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

Littlebits

To: Howard Williams who wrote (12447)	9/24/2013 5:04:36 PM
From: Howard Williams	1 Recommendation Read Replies (1) of 13111

Re Moffitt's SPORE grant award .... This sounds vaguely familiar ..... "This unique project studies targeted therapy with T cells and adoptive transfer of T cells with the goal of boosting the immune system’s response against melanoma cells. It is one of only two such trials in the United States."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next